*Institute of Clinical Chemistry and Pathobiochemistry and
‡Clinic of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University, Magdeburg, Germany;
†Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;
§Department of Internal Medicine I and Clinical Chemistry, German Diabetes Center, University of Heidelberg, Heidelberg, Germany;
‖Joint Heidelberg-Institute for Diabetes and Cancer Translational Diabetes Program, Helmholtz Zentrum München, Neuherberg, Germany;
¶Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany; and
**Department of Biotechnology, University of Sargodha, Sargodha, Pakistan
A.M. and M.M.A.-D. contributed equally to this work.
Correspondence: Prof. Berend Isermann, Institute of Clinical Chemistry and Pathobiochemistry, Otto-von-Guericke-University, Leipziger Straße 44, D-39120 Magdeburg, Germany. Email: [email protected]
